These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6815063)

  • 21. [Evaluation of the results of using aspirin in preventing recurrence of myocardial infarct].
    Halawa B; Mazurek W
    Wiad Lek; 1981 Oct; 34(19):1621-6. PubMed ID: 7039141
    [No Abstract]   [Full Text] [Related]  

  • 22. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Rajagopal V; Bhatt DL
    Semin Thromb Hemost; 2004 Dec; 30(6):649-55. PubMed ID: 15630671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin and secondary mortality after myocardial infarction.
    Elwood PC; Sweetnam PM
    Circulation; 1980 Dec; 62(6 Pt 2):V53-8. PubMed ID: 7438381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin in cardiovascular disease; biochemical pharmacology and clinical trials.
    FitzGerald GA; Mayo G; Price P; Takahara K
    Prog Clin Biol Res; 1989; 301():97-106. PubMed ID: 2678135
    [No Abstract]   [Full Text] [Related]  

  • 25. Translational therapeutics at the platelet vascular interface. Summary.
    FitzGerald GA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588
    [No Abstract]   [Full Text] [Related]  

  • 26. [Primary prevention of coronary heart disease with aspirin].
    Kübler W
    Z Kardiol; 2004; 93 Suppl 2():II33-6. PubMed ID: 15021994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin for the primary prevention of coronary events.
    Mascitelli L; Pezzetta F
    N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12240692
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aspirin in secondary cardiovascular prevention: from clinical studies to daily practice].
    Garnier LF
    Ann Cardiol Angeiol (Paris); 1997 Oct; 46(8):507-12. PubMed ID: 9538362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
    Magnani B; Semprini F
    Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can aspirin prevent recurrence of heart attacks and strokes?
    Kent S
    Geriatrics; 1982 Jan; 37(1):169-72. PubMed ID: 7033047
    [No Abstract]   [Full Text] [Related]  

  • 33. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What dose of aspirin should be prescribed in patients with coronary disease?].
    Montalescot G; Drobinski G; Thomas D
    Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):469-72. PubMed ID: 8669801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.
    Zuern CS; Lindemann S; Gawaz M
    Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive aspirin for women?
    Consum Rep; 2005 Aug; 70(8):48. PubMed ID: 16025577
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin use for prevention of CHD: an FP's story.
    Miser WF
    Am Fam Physician; 2005 Jan; 71(2):250-1, 253. PubMed ID: 15686298
    [No Abstract]   [Full Text] [Related]  

  • 40. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.